Saturday, June 13, 2026

Heatwave Alert: Malaria Risk Soars as Mosquitoes Multiply!

In Daegu, South Korea, the number of mosquitoes has surged due to the hot weather, raising the risk of malaria exposure.

IBS Researchers Advance Conditional Gene Editing With Cross-Species Expansion of SCON System

Researchers at IBS expanded the SCON gene knockout technology, enhancing studies in zebrafish and human stem cells for precise gene control.

AI Anxiety: Nearly 90% of Adults Fear Privacy Breaches and Job Losses!

A study reveals concerns over generative AI's impact on privacy, job displacement, and misinformation among adults aged 20 to 60.

Tag: Alteogen

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us